Ryvu Therapeutics

Ryvu Therapeutics :
Broad oncology pipeline generated from internal discovery engine, including kinase inhibitor, IO/immunometabolism and synthetic lethality programs. Lead compounds SEL120, a potential first in class CDK8 inhibitor for leukemias, lymphomas, and solid tumors in Ph 1b in AML and high-risk MDS (data expected in 2021), and SEL24, a first in class PIM/FLT3 kinase inhibitor in Ph 1/2 in AML (partnered with Menarini, data presented at EHA, June'20). Early stage pipeline addressing emerging solid tumor targets in oncology including STING, HPK1, cancer metabolism.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Clinical Stage
Phase l or ll, Pre-Clinical Stage
Disease Space
Autoimmune, Immuno-Oncology, Metabolic Disorders, Oncology
Finance
Revenues
Industry
Biotechnology, Pharmaceuticals
Investement Strategy
Under the Radar
Listing
Public
Therapeutic Modalities
Gene Therapy, Small Molecule
Website:
Profiles:
Address:
2 Sternbacha Street
Kraków, 30-394
Poland
Kraków, 30-394
Poland
Presentation:
More info:
My account:
Company Participants at Solebury Trout Corporate Access 1x1 Calls - Week of April 13
- Pawel Przewiezlikowski, CEO
Top 10 Holders of Ryvu Therapeutics SA
Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
---|---|---|---|---|---|
Norges Bank Investment Management | 6.28 | 1,003,745 | 0.00 | Funds | 12/31/20 |
FORUM TFI SA | 5.66 | 1,039,738 | 0.00 | Stakes | 9/9/20 |
Aviva Investors Poland Towarzystwo Funduszy Inwestycyjnych SA | 2.46 | 451,185 | 0.00 | Funds | 6/30/20 |
Skarbiec TFI SA | 1.09 | 200,518 | 0.00 | Funds | 6/30/20 |
ESALIENS TFI SA | 0.36 | 65,401 | 0.00 | Funds | 6/30/20 |
Generali Investments TFI SA | 0.30 | 54,542 | 0.00 | Funds | 6/30/20 |
Santander Towarzystwo Funduszy Inwestycyjnych SA | 0.29 | 52,584 | 0.00 | Funds | 6/30/20 |
Millennium TFI SA | 0.27 | 49,477 | 0.00 | Funds | 6/30/20 |
NN Investment Partners Towarzystwo Funduszy Inwestycyjnych SA | 0.09 | 16,895 | 0.00 | Funds | 6/30/20 |
Noble Funds TFI SA | 0.08 | 13,815 | 0.00 | Funds | 6/30/20 |
Ownership data is sourced through FactSet.
Stock Market Data
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by
QuoteMedia.
Terms of Use.